A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer

NCT00069121 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1886

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: Capecitabine
DRUG: Oxaliplatin
DRUG: Leucovorin (LV)
DRUG: 5-Fluorouracil (5-FU)

Sponsor

Hoffmann-La Roche